Janus Henderson Group PLC lifted its stake in shares of Thermo Fisher Scientific Inc (NYSE:TMO) by 2,058.1% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 2,342,046 shares of the medical research company’s stock after purchasing an additional 2,233,522 shares during the period. Janus Henderson Group PLC owned 0.60% of Thermo Fisher Scientific worth $408,620,000 as of its most recent SEC filing.

Several other institutional investors also recently modified their holdings of TMO. Guyasuta Investment Advisors Inc. boosted its holdings in shares of Thermo Fisher Scientific by 0.9% during the 1st quarter. Guyasuta Investment Advisors Inc. now owns 125,173 shares of the medical research company’s stock worth $19,227,000 after purchasing an additional 1,110 shares during the last quarter. Premier Asset Managment LLC boosted its holdings in shares of Thermo Fisher Scientific by 1.3% during the 1st quarter. Premier Asset Managment LLC now owns 80,835 shares of the medical research company’s stock worth $12,416,000 after purchasing an additional 1,010 shares during the last quarter. Beacon Trust Co. boosted its holdings in shares of Thermo Fisher Scientific by 0.6% during the 1st quarter. Beacon Trust Co. now owns 2,159 shares of the medical research company’s stock worth $341,000 after purchasing an additional 12 shares during the last quarter. Savant Capital LLC boosted its holdings in shares of Thermo Fisher Scientific by 61.8% during the 1st quarter. Savant Capital LLC now owns 2,764 shares of the medical research company’s stock worth $425,000 after purchasing an additional 1,056 shares during the last quarter. Finally, Shufro Rose & Co. LLC boosted its holdings in shares of Thermo Fisher Scientific by 10.8% during the 1st quarter. Shufro Rose & Co. LLC now owns 61,307 shares of the medical research company’s stock worth $9,417,000 after purchasing an additional 5,976 shares during the last quarter. Institutional investors and hedge funds own 83.61% of the company’s stock.

COPYRIGHT VIOLATION WARNING: “Janus Henderson Group PLC Buys 2,233,522 Shares of Thermo Fisher Scientific Inc (TMO)” was posted by Watch List News and is the sole property of of Watch List News. If you are viewing this piece of content on another publication, it was illegally copied and reposted in violation of United States & international copyright laws. The original version of this piece of content can be read at https://www.watchlistnews.com/janus-henderson-group-plc-buys-2233522-shares-of-thermo-fisher-scientific-inc-tmo/1679966.html.

In other Thermo Fisher Scientific news, VP Peter E. Hornstra sold 3,894 shares of the business’s stock in a transaction that occurred on Tuesday, September 5th. The stock was sold at an average price of $185.18, for a total value of $721,090.92. Following the sale, the vice president now owns 19,751 shares of the company’s stock, valued at $3,657,490.18. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Jim P. Manzi sold 11,318 shares of the business’s stock in a transaction that occurred on Friday, August 18th. The shares were sold at an average price of $172.94, for a total value of $1,957,334.92. Following the completion of the sale, the director now directly owns 38,757 shares in the company, valued at approximately $6,702,635.58. The disclosure for this sale can be found here. In the last three months, insiders sold 22,738 shares of company stock worth $4,021,512. 0.49% of the stock is owned by corporate insiders.

TMO has been the topic of several recent research reports. Cowen and Company restated an “outperform” rating and set a $220.00 target price (up from $200.00) on shares of Thermo Fisher Scientific in a report on Sunday, September 10th. Leerink Swann boosted their target price on Thermo Fisher Scientific from $190.00 to $207.00 and gave the stock an “outperform” rating in a report on Monday, October 9th. Goldman Sachs Group, Inc. (The) initiated coverage on Thermo Fisher Scientific in a report on Tuesday, September 26th. They set a “buy” rating and a $225.00 target price on the stock. Zacks Investment Research cut Thermo Fisher Scientific from a “buy” rating to a “hold” rating in a report on Tuesday, September 12th. Finally, Deutsche Bank AG set a $226.00 target price on Thermo Fisher Scientific and gave the stock a “buy” rating in a report on Thursday, October 26th. One investment analyst has rated the stock with a hold rating and sixteen have issued a buy rating to the company’s stock. Thermo Fisher Scientific has an average rating of “Buy” and a consensus price target of $205.71.

Shares of Thermo Fisher Scientific Inc (TMO) opened at $193.71 on Friday. The stock has a market capitalization of $77,524.10, a P/E ratio of 21.29, a price-to-earnings-growth ratio of 1.77 and a beta of 1.08. The company has a debt-to-equity ratio of 0.78, a current ratio of 1.26 and a quick ratio of 0.81. Thermo Fisher Scientific Inc has a 12-month low of $139.07 and a 12-month high of $201.20.

Thermo Fisher Scientific (NYSE:TMO) last announced its earnings results on Wednesday, October 25th. The medical research company reported $2.31 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.24 by $0.07. The company had revenue of $5.12 billion for the quarter, compared to analyst estimates of $5.03 billion. Thermo Fisher Scientific had a return on equity of 15.94% and a net margin of 11.73%. The firm’s quarterly revenue was up 13.9% compared to the same quarter last year. During the same quarter in the previous year, the company earned $2.03 earnings per share. equities research analysts expect that Thermo Fisher Scientific Inc will post 9.36 EPS for the current year.

Thermo Fisher Scientific Profile

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc (NYSE:TMO).

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.